# Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression

> **NCT07672431** · NA · NOT_YET_RECRUITING · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 24 (estimated)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

- **DEVICE:** TheraBionic P1

## Key facts

- **NCT ID:** NCT07672431
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-06-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07672431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07672431, "Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07672431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*